SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

Share Price is delayed by 15 minutes
Get Live Data
141.60    -24.20 (-14.60%)
Bid:
140.20
Ask:
144.80
Spread: 4.60 (3.281%)
Market Cap: £241.94m
MCB Live PriceLast checked at - London Stock Exchange

Intraday Mcbride Share Chart

Trading Update

10 Jan 2019 07:00

RNS Number : 6695M
McBride PLC
10 January 2019
 

10 January 2019

 

McBride plc

 

Trading Update

 

McBride plc (the "Group"), the leading European manufacturer and supplier of Contract Manufactured and Private Label products for the domestic Household and professional cleaning and hygiene markets, today provides a trading update for the six months ended 31 December 2018.

 

The Group's first half continuing revenues at constant currency were 10.8% higher than the prior year. Excluding the benefit of first quarter revenues from Danlind, continuing underlying revenues were 6.0% higher. Underlying Household division sales were 5.9% higher, primarily as a result of higher sales in the East and UK regions (up 23.4% and 10.5% respectively).

 

As outlined in our recent AGM trading update, the first half year has seen raw material, packaging and logistics costs higher than anticipated, particularly in the second quarter. These have been partly mitigated by improved sales volumes and lower overheads. The pricing outlook for many of our key raw materials has improved recently and in the absence of this reversing significantly, the Board expects full year earnings to be in line with expectations, with full year profit delivery weighted to the second half.

The sale of the European Personal Care Liquids business was successfully completed during the second quarter and we continue to progress plans for the closure of our UK Aerosols factory in the second half year as expected. The integration of Danlind continued with our Danish factories transitioning onto the McBride ERP system in December.

 

The Group will announce its interim results for the six months ended 31 December 2018 on 21 February.

 

Rik De Vos, Chief Executive said;

 

"The Group has made significant strategic progress in the first half of this financial year completing the sale of Personal Care Liquids, integrating Danlind onto the McBride systems and managing our revenue growth. Margins remain our key focus at present and the recent improvement in the pricing outlook for raw materials following almost two years of significant inflation will see some recovery of the cumulative cost impact to the business. I remain confident that the Group continues to be well positioned to exploit the growth and margin opportunities in the remainder of this financial year and beyond."

 

 

For further information please contact:

 

McBride plc

Rik De Vos, Chief Executive Officer

0161 203 7570

Chris Smith, Chief Financial Officer

0161 203 7570

FTI Consulting

020 3727 1017

Ed Bridges, Nick Hasell

 

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation which came into effect on 3 July 2016.

 

-Ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTQKLFBKFFLBBV
Date   Source Headline
3rd Dec 20184:15 pmRNSIssue of B Shares
19th Nov 20187:00 amRNSCompletion of Disposal
31st Oct 20182:40 pmRNSHolding(s) in Company
24th Oct 20184:21 pmRNSResult of AGM
23rd Oct 20187:00 amRNSAGM Trading Update
16th Oct 201812:52 pmRNSHolding(s) in Company
16th Oct 201812:51 pmRNSHolding(s) in Company
12th Oct 20184:48 pmRNSHolding(s) in Company
21st Sep 20183:59 pmRNSAnnual Financial Report and Notice of AGM
14th Sep 20184:09 pmRNSTotal Voting Rights
13th Sep 20185:01 pmRNSDirector/PDMR Shareholding
12th Sep 20184:33 pmRNSNotification and public disclosure of LTIP
12th Sep 20183:49 pmRNSHolding(s) in Company
6th Sep 20187:00 amRNSFinal Results
13th Aug 20184:20 pmRNSHolding(s) in Company
7th Aug 20181:24 pmRNSHolding(s) in Company
3rd Aug 20182:03 pmRNSHolding(s) in Company
10th Jul 20189:12 amRNSHolding(s) in Company
6th Jul 20183:42 pmRNSHolding(s) in Company
3rd Jul 20187:00 amRNSTrading Update
3rd Jul 20187:00 amRNSSale of European Personal Care liquids
5th Jun 20185:10 pmRNSHolding(s) in Company
5th Jun 201810:24 amRNSIssue of Equity
27th Apr 201812:45 pmRNSHolding(s) in Company
15th Mar 20185:33 pmRNSTR1 - Notification of Major Holdings
12th Mar 20184:54 pmRNSNotification of Major Holdings
2nd Mar 20183:27 pmRNSNotification of Major Holdings
27th Feb 20185:02 pmRNSTotal Voting Rights
27th Feb 20185:02 pmRNSNotification and public disclosure of LTIP
22nd Feb 20187:00 amRNSHalf-year Report
13th Feb 20184:52 pmRNSHolding(s) in Company
11th Jan 20183:50 pmRNSHolding(s) in Company
8th Jan 20187:00 amRNSTrading Update
4th Dec 20174:55 pmRNSIssue of B Shares
16th Nov 201710:40 amRNSHolding(s) in Company
13th Nov 20179:12 amRNSHolding(s) in Company
10th Nov 201710:31 amRNSHolding(s) in Company
25th Oct 20174:35 pmRNSResult of AGM
24th Oct 20177:00 amRNSAGM Trading Update
3rd Oct 20172:30 pmRNSInvestor Day and Site Visits
29th Sep 201712:00 pmRNSCompletion of the acquisition of Danlind a/s
22nd Sep 20174:11 pmRNSAnnual Report and Accounts
22nd Sep 20171:43 pmRNSHolding(s) in Company
13th Sep 20174:00 pmRNSHolding(s) in Company
13th Sep 20172:30 pmRNSDirector/PDMR Shareholding
12th Sep 20174:27 pmRNSDirector/PDMR Shareholding
7th Sep 20177:00 amRNSFinal Results
4th Sep 20177:00 amRNSAcquisition of Danlind a/s
31st Aug 20174:04 pmRNSDirectorate Change
18th Aug 201710:37 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.